RKRobert Konkel

Robert Konkel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert Konkel has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehensive Profiling of Microcystins in Non-Targeted LC-HR-MS Datasets using Mass Spectrometry Query Language (MassQL)

    by Maria Elisabetta Collaro, Sofia Iliakopoulou, Sevasti-Kiriaki Zervou, Jūratė Karosienė, Robert Konkel, Valentina Miele, Angelika-Ioanna Gialleli, Theodoros M. Triantis, Łukasz Wejnerowski, Judita Koreivienė, et al.

    Microcystins (MC) are a critical class of toxic cyanobacterial secondary metabolites, with specific variants such as MC-LR strictly regulated in drinking water. Despite their extensive structural diversity, comprising over 300 known congeners, comprehensive environmental monitoring is severely hindered by the limited availability of commercial reference standards and public tandem mass spectrometry (MS/MS) spectra. To address this analytical bottleneck, we developed a non-targeted mass spectrometry-based computational workflow leveraging the Mass Spectrometry Query Language (MassQL) to enable comprehensive MC profiling. By systematically analyzing the chemical space and fragmentation patterns of all MC congeners documented in the CyanoMetDB database, we classified the congeners into nine structurally distinct groups. Subsequently, we designed and optimized a suite of MassQL queries targeting the conserved MC backbone, group-specific motifs, and individual constituent amino acids. The performance of these custom queries was rigorously evaluated following Feature-Based Molecular Networking (FBMN). Application across three independent cyanobacterial bloom datasets comprising both in-house and public data acquired via qTOF and Orbitrap high-resolution mass spectrometry platforms demonstrated highly satisfactory analytical performance based on recall, precision, F1-scores, and Matthews Correlation Coefficients (MCC). We further demonstrated that MassQL functions as a powerful MC candidate prioritization tool orthogonal to molecular networking. By interrogating MS/MS data for specific structural motifs, this query-based approach enabled the discovery and annotation of novel MC congeners lacking public library spectra, significantly enhancing non-targeted screening for water quality and risk assessment.

  • Open Access

    Molecular-networking-based characterization of cytotoxic metabolites produced by the cyanobacterium Nostoc edaphicum CCNP1411

    by Robert Konkel, Marta Cegłowska, Łukasz Grabowski, Wiktoria Jeleniewska, Monika Zielenkiewicz, Katarzyna Gonera, Grzegorz WęGrzyn, Hanna Mazur-Marzec

  • Open Access

    Screening of 44 Baltic Sea Cyanobacterial Strains for Antibacterial and Quorum Sensing Inhibitory Potential: Selection of Promising Candidates

    by Anna Toruńska-Sitarz, Robert Konkel, Agnieszka Ogrodnicka, Hanna Mazur-Marzec, Magdalena Socha, Donata Overlingė

    Background/Objectives: Cyanobacteria represent a diverse group of microorganisms capable of synthesizing a broad array of biologically active metabolites. Some of these compounds, believed to contribute to the ecological and evolutionary success of cyanobacteria, are increasingly being investigated for potential biomedical and biotechnological applications. They also hold promise in combating the growing threat of antimicrobial resistance (AMR). This screening study aimed to identify Baltic cyanobacterial strains with the potential to produce antibacterial compounds active against streptococci and mycobacteria, as well as quorum sensing inhibitors. Methods/Results: Extracts from forty-four cyanobacterial strains were tested using a broth microdilution assay. The most pronounced activity was observed for extracts derived from two Pseudanabaenaceae strains (KUCC C3 and C4), two Anabaena spp. strains (CCNP 1405 and CCNP 1406), and Aphanizomenon sp. KUCC C1. Inhibition of quorum sensing was the most frequently detected activity, with 30% of the tested extracts inhibiting violacein production in Chromobacterium violaceum ATCC 12472. Growth inhibition of Gram-positive bacteria was less common: 16% of cyanobacterial strains inhibited Streptococcus pyogenes ATCC 12344, and 11% inhibited Mycobacterium smegmatis ATCC 14468. Bioassay-guided fractionation of Aphanizomenon sp. KUCC C1, followed by LC–MS/MS analysis, revealed the presence of glycerolipids and glycolipids, including diacylglycerols (DAGs) and galactosyldiacylglycerols (MGDGs and DGDGs), as major constituents of fractions exhibiting quorum quenching activity. Conclusions: These findings highlight the potential of Baltic cyanobacteria as a source of natural compounds capable of disrupting bacterial communication and growth, offering prospects for the development of novel antimicrobial and anti-virulence agents.

  • Open Access

    Combating Toxic Blooms of Prymnesium parvum: Hydrogen Peroxide Influence on the Haptophyte, Other Phytoplankton Taxa, and Concentrations of Prymnesins Under Experimental Conditions

    by Iwona Jasser, Tümer O. Aykut, Robin Crucitti-Thoo, Agnieszka Pasztaleniec, Robert Konkel, Hanna Mazur-Marzec

    In the summer of 2022, massive blooms of the toxic haptophyte Prymnesium parvum triggered one of the most significant ecological disasters ever recorded in the Odra River, resulting in massive fish and mollusk kills and severe economic damage. Having shown promise for treating other types of phytoplankton blooms, we applied various concentrations of hydrogen peroxide (HP) in an experimental setting using waters collected from the Gliwice Canal; a location with extensive proliferations of P. parvum. In the first stage of our experiment, a single application as low as 14 mg H2O2/L successfully reduced P. parvum biomass and prymnesin concentrations, measured using newly obtained prymnesin standards, with limited negative impact on other phytoplankton. In the second stage of the experiment, we reintroduced an inoculum of the canal water containing the haptophyte bloom. The simulated renewal of the phytoplankton community led to higher P. parvum biomass and elevated prymnesin concentrations, possibly due to nutrient release after HP application or reduced phytoplankton competition. We observed differences in the toxin profile compared with control conditions, suggesting changes in the haptophyte ecotypes in the experimental treatments. The results suggest that HP can be successfully used to combat P. parvum blooms, though caution is warranted with higher concentrations.


  • Open Access

    Cytotoxic Activity of the Baltic Cyanobacterium Pseudanabaena galeata CCNP1313

    by Marta Cegłowska, Robert Konkel, Hanna Mazur-Marzec

    While tropical regions have traditionally been the focus of studies on natural bioactive products, works published within the last decade demonstrate that cyanobacteria from the Baltic Sea also possess significant biotechnological and pharmaceutical potential. The Baltic Pseudanabaena galeata CCNP1313 previously demonstrated activity against breast cancer cell lines (MCF7 and T47D) and several viruses. In the present study, the cytotoxicity of cellular extract and flash chromatography fractions from the strain were evaluated against a wider panel of cancer cells (A549, C-33A, CaSki, DoTC2, HeLa, PC3, SiHa, and T47D). To gain better insight into the compounds potentially responsible for the observed effects, high-resolution mass spectrometry was combined with bioactivity-based molecular networking. Both the extract and hydrophobic fractions showed strong cytotoxicity, particularly against breast cancer cells and selected cervical cancer cells. While HRMS analyses confirmed the production of previously characterised peptides by CCNP1313 (Pseudanabaena galeata peptides and galeapeptins), neither of them was found to be responsible for the activity. Instead, the molecular networking approach linked the cytotoxicity to specific lipid classes, including diacylglycerols (DAGs) and monogalactosyldiacylglycerols (MGDGs). This study highlights the necessity of integrating traditional methods with advanced bioinformatics for the successful discovery of bioactive natural products, especially when complex samples, such as extract or chromatographically separated fractions, are analysed.


  • Genetic, metabolic and toxicological diversity within Prymnesium parvum (Haptophyte) from Polish waterbodies

    by Hanna Mazur-Marzec, Michał Grabski, Robert Konkel, Marta Cegłowska, Zuzanna Cyske, Lidia Gaffke, Łukasz Grabowski, Anastasia Hiskia, Marek Kajs, Triantafyllos Kaloudis, et al.


  • Open Access

    Aeruginosin 525 (AER525) from Cyanobacterium Aphanizomenon Sp. (KUCC C2): A New Serine Proteases Inhibitor

    by Donata Overlingė, Marta Cegłowska, Robert Konkel, Hanna Mazur-Marzec

    Aeruginosins (AERs) are one of the most common classes of cyanobacterial peptides synthesised through a hybrid non-ribosomal peptide synthase/polyketide synthase pathway. They have been found in Microcystis, Nodularia spumigena, Oscillatoria/Plantothrix, and Nostoc. The presence of AER in Aphanizomenon isolated from the Curonian Lagoon was reported for the first time in our previous work. Here, the structure of aeruginosin 525 (AER525), isolated from Aphanizomenon sp. KUCC C2, was characterised based on high-resolution mass spectrometry. This new AER variant shows potent activity against thrombin. It also inhibits trypsin and carboxypeptidase A but has no effect on elastase and chymotrypsin. In terms of the N-terminal residue and biological activity, AER525 displaces some similarity to dysinosins, which belongs to the most potent inhibitors of thrombin among AERs. The findings underline the potential of AER525 as a new anticoagulant agent.


  • Open Access

    Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411

    by Robert Konkel, Aleksandra Milewska, Nguyen Dan Thuc Do, Emilia Barreto Duran, Artur Szczepanski, Jacek Plewka, Ewa Wieczerzak, Sofia Iliakopoulou, Triantafyllos Kaloudis, Dirk Jochmans, et al.


  • Open Access

    Structural Diversity and Biological Activity of Cyanopeptolins Produced by Nostoc edaphicum CCNP1411

    by Robert Konkel, Marta Cegłowska, Karolina Szubert, Ewa Wieczerzak, Sofia Iliakopoulou, Triantafyllos Kaloudis, Hanna Mazur-Marzec

    Cyanopeptolins (CPs) are one of the most commonly occurring class of cyanobacterial nonribosomal peptides. For the majority of these compounds, protease inhibition has been reported. In the current work, the structural diversity of cyanopeptolins produced by Nostoc edaphicum CCNP1411 was explored. As a result, 93 CPs, including 79 new variants, were detected and structurally characterized based on their mass fragmentation spectra. CPs isolated in higher amounts were additionally characterized by NMR. To the best of our knowledge, this is the highest number of cyanopeptides found in one strain. The biological assays performed with the 34 isolated CPs confirmed the significance of the amino acid located between Thr and the unique 3-amino-6-hydroxy-2-piperidone (Ahp) on the activity of the compounds against serine protease and HeLa cancer cells.


  • Open Access

    Anabaenopeptins from Nostoc edaphicum CCNP1411

    by Robert Konkel, Michał Grabski, Marta Cegłowska, Ewa Wieczerzak, Grzegorz Węgrzyn, Hanna Mazur-Marzec

    Cyanobacteria of the Nostoc genus belong to the most prolific sources of bioactive metabolites. In our previous study on Nostoc edaphicum strain CCNP1411, the occurrence of cyanopeptolins and nostocyclopeptides was documented. In the current work, the production of anabaenopeptins (APs) by the strain was studied using genetic and chemical methods. Compatibility between the analysis of the apt gene cluster and the structure of the identified APs was found. Three of the APs, including two new variants, were isolated as pure compounds and tested against four serine proteases and carboxypeptidase A (CPA). The in vitro enzymatic assays showed a typical activity of this class of cyanopeptides, i.e., the most pronounced effects were observed in the case of CPA. The activity of the detected compounds against important metabolic enzymes confirms the pharmaceutical potential of anabaenopeptins.